LTD

Stratasys Publishes Second ESG and Sustainability Report; Achieves Important New Milestones

Retrieved on: 
Thursday, April 11, 2024
Technology, Engineering, Chemicals, Plastics, Automotive Manufacturing, Professional Services, Aerospace, Software, Manufacturing, Electronic Design Automation, Environmental, Social and Governance (ESG), LTD, Safety, Risk, Certification, Mindfulness, Sustainability, Research, Publishing, GRI, Stratasys, ISO, Water, Lung compliance, 3D printing, Environment, Tree, ESG, Additive, CO2, Recycling, Renewable energy

(NASDAQ: SSYS) today announced it has published its second Mindful Manufacturing™ ESG and Sustainability Report in accordance with the Global Reporting Initiative (GRI) standards, fulfilling its commitment to transparency.

Key Points: 
  • (NASDAQ: SSYS) today announced it has published its second Mindful Manufacturing™ ESG and Sustainability Report in accordance with the Global Reporting Initiative (GRI) standards, fulfilling its commitment to transparency.
  • The report includes an extensive overview of activities and advancements in Stratasys’ environmental, social and governance (ESG) programs.
  • By offering a more sustainable alternative to traditional manufacturing, Stratasys introduces solutions for optimized operations and Additive Manufacturing-enabled production.
  • “Executing against our Mindful Manufacturing sustainability strategy is an important step in leading manufacturing towards 3D Printing a Better Tomorrow,” said Rosa Coblens, Vice President, Sustainability.

FIRST FINANCIAL ANNOUNCES CONVERSION OF THE BANK AND TRUST COMPANY TO STATE CHARTERS AND BOARD ELECTION AT ANNUAL MEETING

Retrieved on: 
Tuesday, April 23, 2024
Hendrick Health System, Investment, Bank, Insurance, Communication, Trust, First Financial Bank, Partner (business rank), Edwards Group, Trust Company, Federal Reserve, FDIC, LTD, Bryan–College Station, First, Ernst & Young, Management

ABILENE, Texas, April 23, 2024 /PRNewswire/ -- First Financial Bankshares, Inc. (NASDAQ: FFIN) – today announced at it's 2024 Annual Shareholders' Meeting that its subsidiaries, First Financial Bank, N.A.

Key Points: 
  • ABILENE, Texas, April 23, 2024 /PRNewswire/ -- First Financial Bankshares, Inc. (NASDAQ: FFIN) – today announced at it's 2024 Annual Shareholders' Meeting that its subsidiaries, First Financial Bank, N.A.
  • (the "Bank") and First Financial Trust and Asset Management Company, N.A.
  • (the "Trust Company"), have each successfully converted their charters to a Texas state banking association and a Texas chartered trust company, respectively.
  • The Bank has been a national bank since its inception in 1890 and the Trust Company has been a national trust company since its inception in 2003.

CME Group U.S. Credit Futures to Begin Trading on June 17

Retrieved on: 
Tuesday, April 23, 2024
CME, City, Interest rate, Metal, Risk, OTC, EBS, New York Mercantile Exchange, CME Group, Chicago Board of Trade, NYMEX, COMEX, S&P Dow Jones Indices, S&P, Stock market index, Financial services, Bloomberg, Standard, CBOT, LTD, Security (finance)

CHICAGO, April 23, 2024 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that its new credit futures are scheduled to begin trading on Monday, June 17, 2024, pending regulatory review.

Key Points: 
  • CHICAGO, April 23, 2024 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that its new credit futures are scheduled to begin trading on Monday, June 17, 2024, pending regulatory review.
  • Launching alongside the company's leading U.S. Treasury complex, CME Group credit futures will be the first futures contracts to help market participants manage duration risk through an intercommodity spread with U.S. Treasury futures.
  • "Designed for efficiency, our credit futures will support spread trading with automatic margin offsets against our Interest Rate and Equity Index futures."
  • The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.

CME Group International Average Daily Volume Reached Quarterly Record of 7.4 Million Contracts in Q1 2024

Retrieved on: 
Monday, April 15, 2024
Globalization, Commodity, CME, City, Metal, Uncertainty, OTC, EBS, New York Mercantile Exchange, CME Group, Growth, Chicago Board of Trade, NYMEX, COMEX, S&P Dow Jones Indices, S&P, Risk management, Senior, Financial services, Standard, CBOT, LTD, ADV

LONDON and SINGAPORE, April 15, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 7.4 million contracts in Q1 2024, up 2% year on year.

Key Points: 
  • LONDON and SINGAPORE, April 15, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 7.4 million contracts in Q1 2024, up 2% year on year.
  • "Our record Q1 international ADV was driven by significant increases in commodities volume across EMEA and Asia Pacific, demonstrating how our clients turn to these products to hedge price risk."
  • In Q1 2024, Europe, Middle East and Africa ADV hit 5.4 million contracts, up 6% from Q1 2023.
  • Asia Pacific ADV stood at 1.7 million contracts in Q1 2024.

CME Group Micro U.S. Treasury Futures Surpass 100,000 Contracts Traded

Retrieved on: 
Tuesday, April 9, 2024
United States Treasury security, CME, City, Metal, OTC, EBS, New York Mercantile Exchange, CME Group, Chicago Board of Trade, NYMEX, COMEX, S&P Dow Jones Indices, S&P, Risk management, Interest, Financial services, Standard, CBOT, FX, LTD, Security (finance)

"As the world's most liquid market for U.S. Treasury futures, CME Group is pleased that so many of our global clients are incorporating smaller-sized Micro U.S. Treasury futures into their trading strategies," said Agha Mirza, CME Group Global Head of Interest Rates and OTC Products.

Key Points: 
  • "As the world's most liquid market for U.S. Treasury futures, CME Group is pleased that so many of our global clients are incorporating smaller-sized Micro U.S. Treasury futures into their trading strategies," said Agha Mirza, CME Group Global Head of Interest Rates and OTC Products.
  • CME Group recently reported its highest-ever Q1 average daily volume of 7.8 million contracts in U.S. Treasury futures and options, an increase of 12% year-over-year.
  • Micro U.S. Treasury futures are cash-settled and one-tenth of the size of Ultra 10-Year U.S. Treasury Note futures and Ultra U.S. Treasury Bond futures.
  • The contracts receive automatic margin offsets against existing CME Group Interest Rate futures, and are listed by, and subject to, the rules of CBOT.

Inheritance, Dreams, Future - The Successful Holding of the 2nd HUAPOP Creative Festival in Shenzhen in 2024

Retrieved on: 
Sunday, March 31, 2024
Belt, Southern University, LTD, HUA, Associate, Rejuvenation, Dream, Civilization, Party, Federation, Dafen, Tourism

Shenzhen, China--(Newsfile Corp. - March 31, 2024) - The 2nd HUAPOP Creative Festival with the theme of "Inheritance, Dreams, Future" was held in the forefront city of Shenzhen, a hub of reform, openness, and fashion, on March 26, 2024.

Key Points: 
  • Shenzhen, China--(Newsfile Corp. - March 31, 2024) - The 2nd HUAPOP Creative Festival with the theme of "Inheritance, Dreams, Future" was held in the forefront city of Shenzhen, a hub of reform, openness, and fashion, on March 26, 2024.
  • The festival, organized by the HUAPOP Creative Festival Organizing Committee, aims to promote and showcase the creative achievements of the "HUA" culture from 2022-2023, and to promote and lead the new trend of global "HUAPOP."
  • The 2nd HUAPOP Creative Festival, jointly organized by the HUAPOP Creative Festival Organizing Committee, HUAPOP Industrial Economic Research Institute, National Base For International Cultural Trade (Shenzhen), and 36Kr, has been planned and prepared for nearly 10 months.
  • The 2nd HUAPOP Creative Festival continues the format of "rankings" and selects the HUAPOP Creative Ranking, HUAPOP Popularity Ranking, HUAPOP Institutional Ranking, and HUAPOP City Index.

Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

Retrieved on: 
Tuesday, April 9, 2024
Diagnosis, X-ray, LTD, Cardiology, Patient, Science, Radiology, SCL, Department of Tourism (Philippines), NANO, Teleradiology, ARC, Marketing, Medical device

PETAH TIKVA, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced a new collaboration to advance the Nanox.ARC 3D imaging system and Nanox artificial intelligence (AI) solutions in Korea with AhealthZ – a distributor of healthcare services and devices – and SCL Science, AhealthZ’s affiliated company and subsidiary of global healthcare group SCL (Seoul Clinical Laboratories).

Key Points: 
  • Under the collaboration, AhealthZ plans to assist Nanox in efforts to secure local authorizations and licenses to enable the importation, marketing and sales of the Nanox.ARC in South Korea.
  • The Nanox.ARC is a digital tomosynthesis system that uses multiple sources of X-rays to produce a three-dimensional, tomographic images.
  • The collaboration will also include SCL Science integrating Nanox’s AI solutions in remote image analysis and other operations.
  • “We are excited to work with AhealthZ and SCL Science to bring our comprehensive medical imaging solutions to South Korea, a country of over 51 million people and one of the world’s most advanced technological markets,” said Erez Meltzer, Nanox Chief Executive Officer.

Global Technologies, LTD Closes on the Sale of Its Commercial Property in Georgia

Retrieved on: 
Wednesday, April 3, 2024
OTC Markets Group, LTD, Sale, Acquisition

Parsippany, NJ, April 03, 2024 (GLOBE NEWSWIRE) -- Global Technologies Ltd. (OTC Pink:GTLL) (the “Company” or “Global”) a company with operations in the acquisition and redevelopment of distressed properties and customer sales management is pleased to announce that it has closed on the sale of its commercial building located in Sylvester, GA.

Key Points: 
  • Parsippany, NJ, April 03, 2024 (GLOBE NEWSWIRE) -- Global Technologies Ltd. (OTC Pink:GTLL) (the “Company” or “Global”) a company with operations in the acquisition and redevelopment of distressed properties and customer sales management is pleased to announce that it has closed on the sale of its commercial building located in Sylvester, GA.
    On March 26, 2024, the Company closed on the sale of its commercial building, which was part of the Foxx Trot Tango purchase that took place in June of 2023.
  • The net funds received by the Company will be utilized for operational expenses to help further support and advance both operating businesses: 10 Fold Services and GOe3.
  • Fredrick K. Cutcher, CEO of Global Technologies, LTD, stated “The sale of our commercial property serves as yet another successful transaction that we have been able to deliver upon early on in 2024.
  • The net funds available from the sale of this property will be instrumental for us to continue on a path of success for both 10 Fold Services and GOe3, as we move into the next quarter of 2024 and beyond.” Mr. Cutcher continued, “This year has started off on a very positive note for us with the closing of the GOe3 acquisition and the expansion of the 10 Fold Services operations.”
    The Company looks forward to providing shareholders with additional updates on operations in the near future.

Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, April 1, 2024
Research, PIN, LTD, Intermountain Health, Radiology, Exercise, Medical imaging, Patient, Health, Fatty liver disease, Action Replay, Policy, Sale, AI, D&O, Google Images, Teleradiology, NANO, GAAP, ARC, Depreciation, Marketing, FDA, Vertebral compression fracture, Hand, Cryptocurrency

PETAH TIKVA, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2023 and provided a business update.

Key Points: 
  • Fourth Quarter 2023 Highlights and Recent Developments:
    Generated $2.4 million in revenue in the fourth quarter of 2023, compared to $2.1 million in the fourth quarter of 2022.
  • “I am incredibly proud to announce another strong quarter and year for Nanox,” said Erez Meltzer, Nanox Chief Executive Officer.
  • “First and foremost, we achieved a pivotal milestone in fiscal year 2023, getting FDA clearance for the Nanox ARC systems and deploying them in the key US market.
  • During the fourth quarter of 2023, Nanox AI continued to complete pilot programs with marketplaces, marketplace costumers and health organizations in anticipation of full deployment of its products.

AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Friday, March 29, 2024
AEON, Steps, U.S. FDA, LTD, Headache, Patient, Migraine, Investment, Alembic Pharmaceuticals, Safety, FDA, Food, Pharmaceutical industry

IRVINE, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions, announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.

Key Points: 
  • We are now well-positioned to plan for the initiation of our pivotal Phase 3 program,” commented Marc Forth, AEON’s President and Chief Executive Officer.
  • “Recently, we announced plans to conduct an interim analysis of our ongoing Phase 2 study of ABP-450 as a preventive treatment for chronic migraine, which completed enrollment in December 2023.
  • On track to announce topline results from the Phase 2 study of ABP-450 as a preventive treatment for chronic migraine in the third quarter of 2024.
  • Episodic Migraine Program Next Steps – The Company is continuing to plan for the initiation of its proposed pivotal Phase 3 program for ABP-450.